Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 17, 2026, titled “Zydus and Lupin sign licensing agreement for co-marketing innovative Semaglutide Injection in India”. |SUBJECT: Press Release
Thursday, Sep 17, 2026